We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Cobalt Challenges Patents For AstraZeneca's Crestor

Law360 (November 1, 2007, 12:00 AM EDT) -- Cobalt Pharmaceuticals Inc. is seeking U.S. regulatory approval to make and sell a generic version of Astrazeneca PLC's cholesterol drug Crestor, claiming that two patents for the drug, which had U.S....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.